WBI Power Factor High Dividend ETF
WBIY - ETF AI Analysis
Top Page
WBI Power Factor High Dividend ETF (WBIY)
WBIY, the WBI Power Factor High Dividend ETF, has an overall rating that suggests it offers a generally solid but not outstanding mix of income and quality. Strong holdings like Verizon and PepsiCo, which show robust financial performance, healthy cash flows, and supportive valuations, help lift the fund’s appeal for dividend-focused investors. However, positions such as HP and Altria, where financial or operational concerns and leverage issues are more pronounced, along with exposure to companies facing high debt or competitive pressures, introduce risk and may have held the rating back, with a key risk being concentration in high-dividend names that can be sensitive to leverage and sector-specific challenges.
WBIY vs. SPDR S&P 500 ETF (SPY)
- AUM
- 63.07M
- Region
- North America
- Expense Ratio
- 1.00%
- Beta
- 0.54
- Issuer
- WBI Shares
- Inception Date
- Dec 19, 2016
- Dividend Yield
- 3.78%
- Asset Class
- Equity
- Index Tracked
- Solactive Power FactorTM High Dividend (GR)
WBIY Summary
WBI Power Factor High Dividend ETF (WBIY) is a fund that follows the Solactive Power Factor High Dividend index, focusing on U.S. companies that pay high dividends. It owns a mix of businesses across many sectors, including well-known names like Pfizer, Verizon, AT&T, and Clorox. Someone might invest in WBIY to build a steady income stream from dividends while still staying diversified across different industries. A key risk is that high-dividend stocks can still fall in value with the overall stock market, and the fund’s performance depends heavily on U.S. companies.
How much will it cost me?
This ETF has an expense ratio of 0.97%, which means you’ll pay about $9.70 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed, using a specialized strategy to select high-dividend stocks rather than simply tracking a broad market index.
What would affect this ETF?
This U.S.-focused high dividend ETF could benefit if interest rates fall, making its payouts more attractive, and if defensive areas like utilities, consumer staples, and telecoms (including holdings such as Verizon, AT&T, and Clorox) stay steady during economic slowdowns. On the other hand, rising rates, tighter regulation of telecom and financial companies, or pressure on dividend-heavy sectors like utilities and tobacco (such as Altria) could hurt both share prices and the fund’s ability to maintain high income.
WBIY Top 10 Holdings
WBIY leans heavily on steady, U.S.-based dividend payers, with a mix of telecom, consumer staples, and financial names steering the ship. Pfizer and Altria have been rising, giving the fund a welcome boost, while Accenture’s recent strength adds a touch of growth flair to this income-focused lineup. On the flip side, Corteva has been dragging performance, and AT&T’s lagging share price isn’t helping. Clorox and Edison International are more mixed, reflecting the fund’s tilt toward defensive, income-rich sectors rather than high-flying growth stories.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Pfizer | 5.46% | $3.45M | $167.35B | 20.38% | 74Outperform | |
| Clorox | 5.30% | $3.35M | $12.91B | 1.82% | 55Neutral | |
| Edison International | 5.02% | $3.17M | $23.16B | 4.99% | 77Outperform | |
| Altria Group | 4.92% | $3.11M | $126.99B | 32.65% | 64Neutral | |
| Verizon | 4.86% | $3.07M | $191.94B | 16.21% | 81Outperform | |
| AT&T | 4.34% | $2.75M | $147.80B | -11.64% | 71Outperform | |
| Corteva | 4.29% | $2.71M | $8.12B | -81.44% | 75Outperform | |
| Fidelity National Info | 3.73% | $2.36M | $14.59B | -56.74% | 64Neutral | |
| Accenture | 3.14% | $1.98M | $152.79B | 5.71% | 79Outperform | |
| Fidelity National Financial | 2.95% | $1.87M | $11.85B | -23.18% | 74Outperform |
WBIY Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For WBIY, the sentiment is Positive. The current price of 37.62 is above the 20-day moving average (MA) of 36.55, above the 50-day MA of 36.30, and above the 200-day MA of 34.96, indicating a bullish trend. The MACD of 0.48 indicates Negative momentum. The RSI at 60.68 is Neutral, neither overbought nor oversold. The STOCH value of 58.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for WBIY.
WBIY Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $37.62 | $39.00(3.66% Upside) | $63.07M | 1.00% | 70Outperform | |
| $56.82 | $61.27(7.82% Upside) | $96.72M | 0.40% | 66Neutral | |
| $32.96 | $35.51(7.71% Upside) | $79.42M | 0.09% | 68Neutral | |
| $25.67 | $30.49(18.77% Upside) | $74.23M | 0.50% | 73Outperform | |
| $28.40 | $32.05(12.83% Upside) | $55.20M | 0.35% | 70Neutral | |
| $34.56 | $37.48(8.46% Upside) | $55.95M | 0.26% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| WBIY | WBI Power Factor High Dividend ETF | 37.62 | 7.61 | 25.36% | |
| PAYR | Federated Hermes Enhanced Income ETF | 56.82 | 10.13 | 21.70% | |
| XUDV | Franklin U.S. Dividend Multiplier Index ETF | 32.96 | 7.49 | 29.38% | |
| HQDG | Raub Brock Dividend Growth ETF | 25.67 | 0.68 | 2.70% | |
| FDIV | MarketDesk Focused U.S. Dividend ETF | 28.40 | 2.30 | 8.81% | |
| NUDV | Nuveen ESG Dividend ETF | 34.56 | 5.66 | 19.56% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
